191 related articles for article (PubMed ID: 17138562)
1. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner.
Hambrock A; de Oliveira Franz CB; Hiller S; Grenz A; Ackermann S; Schulze DU; Drews G; Osswald H
J Biol Chem; 2007 Feb; 282(5):3347-56. PubMed ID: 17138562
[TBL] [Abstract][Full Text] [Related]
2. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
[TBL] [Abstract][Full Text] [Related]
3. 17beta-Estradiol modulates apoptosis in pancreatic beta-cells by specific involvement of the sulfonylurea receptor (SUR) isoform SUR1.
Ackermann S; Hiller S; Osswald H; Lösle M; Grenz A; Hambrock A
J Biol Chem; 2009 Feb; 284(8):4905-13. PubMed ID: 19095654
[TBL] [Abstract][Full Text] [Related]
4. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
5. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
6. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
Matsuoka T; Matsushita K; Katayama Y; Fujita A; Inageda K; Tanemoto M; Inanobe A; Yamashita S; Matsuzawa Y; Kurachi Y
Circ Res; 2000 Nov; 87(10):873-80. PubMed ID: 11073882
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.
Nagashima K; Takahashi A; Ikeda H; Hamasaki A; Kuwamura N; Yamada Y; Seino Y
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S75-8. PubMed ID: 15563985
[TBL] [Abstract][Full Text] [Related]
8. Lipids modulate ligand binding to sulphonylurea receptors.
Klein A; Lichtenberg J; Stephan D; Quast U
Br J Pharmacol; 2005 Aug; 145(7):907-15. PubMed ID: 15895108
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the molecular assembly of beta-cell K(ATP) channels.
Mikhailov MV; Mikhailova EA; Ashcroft SJ
FEBS Lett; 2000 Sep; 482(1-2):59-64. PubMed ID: 11018523
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
Fang K; Csanády L; Chan KW
J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
[TBL] [Abstract][Full Text] [Related]
11. A functional role of the C-terminal 42 amino acids of SUR2A and SUR2B in the physiology and pharmacology of cardiovascular ATP-sensitive K(+) channels.
Yamada M; Kurachi Y
J Mol Cell Cardiol; 2005 Jul; 39(1):1-6. PubMed ID: 15978900
[TBL] [Abstract][Full Text] [Related]
12. Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.
Gribble FM; Reimann F
J Diabetes Complications; 2003; 17(2 Suppl):11-5. PubMed ID: 12623163
[TBL] [Abstract][Full Text] [Related]
13. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
14. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
[TBL] [Abstract][Full Text] [Related]
15. Effect of two amino acids in TM17 of Sulfonylurea receptor SUR1 on the binding of ATP-sensitive K+ channel modulators.
Hambrock A; Kayar T; Stumpp D; Osswald H
Diabetes; 2004 Dec; 53 Suppl 3():S128-34. PubMed ID: 15561900
[TBL] [Abstract][Full Text] [Related]
16. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
Moritz W; Leech CA; Ferrer J; Habener JF
Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
[TBL] [Abstract][Full Text] [Related]
17. Morphological localisation of sulfonylurea receptor 1 in endocrine cells of human, mouse and rat pancreas.
Guiot Y; Stevens M; Marhfour I; Stiernet P; Mikhailov M; Ashcroft SJH; Rahier J; Henquin JC; Sempoux C
Diabetologia; 2007 Sep; 50(9):1889-1899. PubMed ID: 17593344
[TBL] [Abstract][Full Text] [Related]
18. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
19. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
[TBL] [Abstract][Full Text] [Related]
20. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
Tanemoto M; Vanoye CG; Dong K; Welch R; Abe T; Hebert SC; Xu JZ
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F659-66. PubMed ID: 10751228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
